These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 15814644)

  • 1. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
    Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA
    Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogens decrease gamma-ray-induced senescence and maintain cell cycle progression in breast cancer cells independently of p53.
    Toillon RA; Magné N; Laïos I; Castadot P; Kinnaert E; Van Houtte P; Desmedt C; Leclercq G; Lacroix M
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1187-200. PubMed ID: 17336220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal p53 status and function despite the development of drug resistance in human breast cancer cells.
    Wosikowski K; Regis JT; Robey RW; Alvarez M; Buters JT; Gudas JM; Bates SE
    Cell Growth Differ; 1995 Nov; 6(11):1395-403. PubMed ID: 8562478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1.
    Vigneron A; Roninson IB; Gamelin E; Coqueret O
    Cancer Res; 2005 Oct; 65(19):8927-35. PubMed ID: 16204065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs.
    Chang BD; Xuan Y; Broude EV; Zhu H; Schott B; Fang J; Roninson IB
    Oncogene; 1999 Aug; 18(34):4808-18. PubMed ID: 10490814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Bax, Bad and Bcl-2 proteins under x-radiation effect towards human breast carcinoma MCF-7 cells and their doxorubicin-resistant derivatives.
    Chorna IV; Datsyuk LO; Stoika RS
    Exp Oncol; 2005 Sep; 27(3):196-201. PubMed ID: 16244580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase activity, expression of Bcl-2 and cell cycle regulation in doxorubicin resistant gastric carcinoma cell lines.
    Yoon KA; Ku JL; Yang JO; Park JG
    Int J Mol Med; 2003 Mar; 11(3):343-8. PubMed ID: 12579337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
    Villeneuve DJ; Hembruff SL; Veitch Z; Cecchetto M; Dew WA; Parissenti AM
    Breast Cancer Res Treat; 2006 Mar; 96(1):17-39. PubMed ID: 16322897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes.
    Assmus B; Urbich C; Aicher A; Hofmann WK; Haendeler J; Rössig L; Spyridopoulos I; Zeiher AM; Dimmeler S
    Circ Res; 2003 May; 92(9):1049-55. PubMed ID: 12676819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells.
    Ravizza R; Gariboldi MB; Molteni R; Monti E
    Oncol Rep; 2008 Sep; 20(3):625-30. PubMed ID: 18695915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of bcl-2 and p21waf1 proteins in response of human breast cancer cell clones to Tomudex.
    Orlandi L; Bearzatto A; Abolafio G; De Marco C; Daidone MG; Zaffaroni N
    Br J Cancer; 1999 Sep; 81(2):252-60. PubMed ID: 10496350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
    Gewirtz DA; Di X; Walker TD; Sawyer ST
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage.
    Maejima Y; Adachi S; Ito H; Hirao K; Isobe M
    Aging Cell; 2008 Mar; 7(2):125-36. PubMed ID: 18031568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
    Moh MC; Zhang T; Lee LH; Shen S
    Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell.
    Hattangadi DK; DeMasters GA; Walker TD; Jones KR; Di X; Newsham IF; Gewirtz DA
    Biochem Pharmacol; 2004 Nov; 68(9):1699-708. PubMed ID: 15450935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F-1 is a critical modulator of cellular senescence in human cancer.
    Park C; Lee I; Kang WK
    Int J Mol Med; 2006 May; 17(5):715-20. PubMed ID: 16596252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of human breast carcinoma MCF-7 cells differing in their resistance to doxorubicin: effect of ionizing radiation on apoptosis and TGF-beta production.
    Chorna I; Bilyy R; Datsyuk L; Stoika R
    Exp Oncol; 2004 Jun; 26(2):111-7. PubMed ID: 15273662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
    Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells.
    Li X; Lu Y; Liang K; Liu B; Fan Z
    Breast Cancer Res; 2005; 7(5):R589-97. PubMed ID: 16168102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.